A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to
Severely Active Crohn's Disease
Research Question:
Does guselkumab help patients with Crohn's disease?
Basic Study Information
Purpose:
The purpose of this program is to evaluate the efficacy and safety of guselkumab (an
injection under the skin) in participants with Crohn's disease.
Inclusion Criteria: Have Crohn's disease or fistulizing Crohn's disease for at least
3 months duration (a minimum of 12 weeks). Have demonstrated intolerance or inadequate
response to conventional or biologic therapy for Chrohn's disease.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher: Lawrence Saubermann
Study Contact Information
Study Coordinator: Study Contact
Phone: (844) 434-4210
Email: JNJ.CT@sylogent.com
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search